This is a preview of subscription content, log in via an institution to check access.
Reference
Toffoli G, et al. The genotype for DPYD risk variants in colorectal cancer patients and the related toxicity management costs in clinical practice. Clinical Pharmacology and Therapeutics : 19 Oct 2018. Available from: URL: http://doi.org/10.1002/cpt.1257
Rights and permissions
About this article
Cite this article
Pre-fluoropyrimidine genotyping saves toxicity-related costs. PharmacoEcon Outcomes News 815, 25 (2018). https://doi.org/10.1007/s40274-018-5406-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-5406-0